Biologics May Prevent Cardiovascular Events in RA Patients
Study Finds Mirikizumab Superior to Secukinumab for Plaque Psoriasis
FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis
Biosimilar Prescribing Habits in the VA & Academic Settings
Biosimilars Are Slowly Climbing Toward Acceptance in Rheumatology
U.S. Insurers Often Limit Biosimilar Coverage
Rheumatology Biologic Expertise Valued for COVID-19 Treatment Decisions
Rheumatoid Arthritis Therapy Update: What’s Changed & What’s the Same
Pediatric Cases Require Special Considerations & Aggressive Treatment Plans
- 1
- 2
- 3
- …
- 32
- Next Page »